Usana Health Sciences "buy"

08/28/07 - D.A. Davidson & Co.

NEW YORK, August 28 (newratings.com) - Analyst Timothy S Ramey of DA Davidson maintains his "buy" rating on Usana Health Sciences Inc (USNA). The 12-18 month target price is set to $60.

In a research note published yesterday, the analyst mentions that the mood at the company’s global convention this past week was upbeat. The Minkow controversy does not seem to have impacted Usana Health Sciences’ business or motivation of the company’s employees, who seemed disinterested in the allegations of the convicted felon Barry Minkow, the analyst says. Given the information regarding the sincerity and integrity of the company and its management team, the charges against Usana Health Sciences do not seem realistic, DA Davidson adds.